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Abstract
Improving the economic performance of pharmacies need to economic and financial indicators. Despite this necessity, 
economic and financial performance indicators have not been identified comprehensively in the pharmacy setting. Thus 
the aim of this study is to determine the economic and financial performance assessment criteria of the pharmacies by 
specialist’s point of view. This study is a qualitative study in which experts and professional’s point of view were gathered 
by  focus group discussion. 15 health system experts were selected by purposive sampling approach. Data from focus 
group discussions (FGD) were analyzed by thematic analysis method. Twelve main themes in two scopes were obtained 
to assess the economic and financial performance of the pharmacy by review of specialists view. These themes are waste 
rate, profitability, cost control, financial management, economic and political issues, pharmacist, doctor, medical insurance, 
management system, pharmaceutical companies, cultural issues and public or private administration system of pharmacy.
Based on the results of this study, the most important criteria to evaluate the financial and economic performance of 
pharmacies were identified. These results can be used for to economic and financial performance evaluation of pharmacies.
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1.  Introduction
In recent decades, the growth of technology, knowledge 
and peoples’ expectation has lead to inflation of health 
costs and has created financial problems in health 
services1. Because of limitation of health resources and 
the importance of providing affordable services, one of 
the important tasks of health system decision-makers 
in each country to evaluate the economic performance 
of health service centers2. Unlike the traditional concept 
of pharmacy (a place for the preparation and delivery 
of drugs), today, the pharmacy is a growing industry. In 
recent years the costs of medicines in primary and hospital 
care have increased and account for 15% of annual health 
cost in developed countries3.
Economic performance assessment is a key element of 
health system and this issue is more important in drugs 
and medicines. Economic assessments of pharmacy are 
related to pharmacy inputs and outputs, efficient use of 
resources and provide the evidence for correct decision 
making. In 1979, the Cost-Benefit Analysis (CBA) of 
pharmacy services was reported for the first time. At that 
time, the authors knew, evaluating the benefits and costs 
of pharmacy services was the only way to increase medical 
professional services4. Economic evaluation models in the 
United States are similar to CBA studies and represents 
45.6 billion dollars cost savings and 120,000 lifesavings. 
However, despite these figures, the economic evaluation 
system is not well designed and leads to misconceptions 
about the health economic performance of Europe. But 
fortunately, it has been a good starting point to embrace 
economic evaluation by pharmacies5. This study  was 
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conducted to assess the criteria for performance of 
pharmacies economically and financially.
2.  Materials and Methods
This study is a Qualitative research and the focus group 
discussions were used to gather the views of experts. 
Participants in this research were pharmacists, faculty 
of  financial, budget management and Medical Sciences, 
who had an average of 17 years of executive experience. 
In this study, the purposive sampling approach was 
used. Sampling and data collection continues until 
data saturation. In this study, a total of 15 experts were 
interviewed in 2 group discussions. Discussion group 
was coordinated, planned and conducted in a proper 
condition and each session lasted from 90 to 120 minutes.
All FGDs were recorded by the digital sound 
recording device and transcribed verbatim, then analyzed 
by thematic analysis. All recorded files were carefully 
listened to several times and their texts reviewed over and 
over. All texts were read several times and by breaking 
any text portion, quotes as significant parts of the themes 
were extracted. For rigor, consistency and integrity of 
data, after the end of each part of the group discussion, 
topics were concluded, participant agreements about the 
data were asked and accuracy confirmation was received 
from their perspective. Two faculty members who are 
experienced in qualitative studies analyzed the contents of 
the implemented meetings and later the final agreement 
was incorporated. In this study, ethical considerations, 
such as oral consent of participants, confidentiality 
of information and names of people and the right to 
withdraw from the study at any time were considered.
3.  Results
In this study, a total of 12 main themes and 101 sub-themes 
were identified in two scopes including the necessity 
of evaluating the financial and economic performance 
of pharmacy and factors affecting the financial and 
economic performance of pharmacies that are presented 
in Table 1 and Table 2. Each of the main themes were 
described separately.
Table 1.    The importance of economic and financial  performance evaluation of pharmacy from the health 
professionals and experts' perspective
Sub-themeMain theme 
- Storage and depot drugs 
- Non-expired drugs based on Stoke quarter 
- Pharmacy inventory control 
- Unpredictable number of clients 
1. Waste reduction
- Difference in profit margins of selling drugs 
- Determination of net  and gross profit of drugs 
- Determination of expected profit of pharmacy 
- Purchase of drugs Award 
- Lack of  measuring profitability as a routine  
- Profit margins of drug 
- The impact of medical tourism 
- Sale of OTC drugs 
2. Profitability
- Rental costs at the pharmacy 
- Fixed and current prices 
- Personnel costs 
- Depreciation costs 
- Warehouse handling costs 
- Energy costs 
3. Cost control
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- Raw data but lack of financial reporting 
- Capabilities and problems of HIS system for reporting  
- Monitoring the financial balance sheet 
- Pharmacy accounting  
- Pharmacy debt to pharmaceutical companies  
- Delayed registration buying process in HIS system 
- Defects in financial software to display Income Profile 
- The minimum and maximum inventory in stock 
- Circulation of capital  
- The collection period 
- The beginning and end of year inventory 
- The lack of data in the financial system 
- Lack of awareness about the need and importance of recording financial information 
- Correct and timely registration of financial information 
- Pharmacy input and output recording in the financial system 
- Analysis of financial data 




- Free market for pharmaceutical companies 
- Dynamic economy 
- Unpredictable health system 
- Taxation and Finance 
- The government sanctions 
- The government's fiscal policy 
- Drug distribution system in the country 
- High  rates of bank profit 
5. Political and economic 
issues
Table 2.    Factors affecting financial and economic performance of pharmacy from the perspective of health 
professionals and experts
Sub-themesThe main themes
- How to buy drugs (buy volume, logical and strategic) 
- Determination of  the amount of the purchase of pharmaceutical companies 
- Buy required items  
- Pharmacy  processes management  
- Pharmacy personnel management 
- Patient management for the delivery of appropriate medicines 
- Pharmacist's relationship with groups and various sectors 
-  Management and accounting  knowledge of a pharmacist 
- Technical Director's authority  related to  hospital departments  
- Presence of a large number of clinical pharmacists in good hospitals  
- Pharmacist's technical right 
- Monitoring of drug interactions 
1. Pharmacist 
- Brands used by doctors 
- The unique physicians in hospitals 
- There is a doctor's office in the pharmacy 
- Prescribing systems used by physicians 
- Corrosion created in prescriptions by doctors 
- Lack of instructions for the physician to use the drug sector 
2. Physician
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3.1 Waste Reduction
Due to the limitation of financial resource waste reduction 
is one of the essential solutions for resource conservation. 
Knowledge about Drug Purchase, Inventory control and 
method of disposing the expired drugs were emphasized 
by the participants. “We try not to purchase expired 
medication because our shopping is based on three 
months’ supply” (P.9). “We all know that financial turnover 
should be right e.g. do not shop something that stays for a 
a long time in stock and leads to negative turnover”(P.1).
3.2 Profitability
One of the most important issues that participants 
emphasized in the discussion group was the question of 
profitability of their pharmacy. In this regard issues such 
as the difference in the profitability of pharmacies, drug 
- Health insurance deductions 
- Late or untimely payment of health insurance 
- Unilateral insurance system 
- Insurance system differences in comparision with other countries 
- High deductions compared with other countries 
- Absence of a fixed system in Insurance 
- Costs imposed  on  the insurance by providing software  and CD-ROM 
- Hidden deductions 
3. Medical insurance
- Keep the Hospital committees for Drug, Therapeutic and Deductions active,  
   therapeutic  and  deductions committees of hospital 
- The prorated deductions to all departments of the hospital  
- Pharmacy incomes spent in other parts of the hospital  
- Distribution and delivery  process of medicines in the hospital 
- Financial resource management 
- The new financial system 
- Role of Pharmacists Association 
- Role of Food and Drug Department  
- Seasonal scarcity of medicines 
- Therapeutic interest in Health Ministry 
- Supervision of university authorities to prevent issues of corruption and fraud  
   management  
- Financial knowledge of managers 
- Delays in the reimbursement to pharmaceutical companies 
4. Management system
- Mafia in the chain of companies  
- Different importers of medications 
- Different prices for different companies 
- Reject expired drugs from pharmaceutical companies 
- Investment pharmacies for all brands of pharmaceuticals 
- Promotion and marketing of pharmaceutical companies
5. Pharmaceutical compa-
nies
- Community opinion about the pharmacy  
- Clients culture of pharmacy 
- Culture of the pharmaceutical society  
- Conflict between public culture and academic cycle 
- Traditional and personalised pharmacy management system 
- Customer focus and respect to customer
6. Cultural issues
- The number of personnel in the public and private sectors 
- Costs and cost control in the public and private sectors 
- Public and private sector, goals 
- Sale of subsidized  and  essential drugs in the public sector 
- Rents in the public sector
7. Public or private 
management system of 
pharmacy
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profit margins, impact of medical tourism, purchase of 
medication award, sale of non-prescription drugs (OTC) 
and expected profit of pharmacies are very important and 
need to be considered. “In relation to the financial and 
economic evaluation of the pharmacy or hospital, the 
first argument is that in addition to providing technically 
appropriate and acceptable services, it must be profitable 
and the pharmacy must show a 20% profit. (P.8). “Iran 
is the only country where profit is so low for medication 
sales. Now we have a 70% or 80% profit in the European 
countries. In America the drug profit is 68% with less 
investment whereas here it is just the opposite.
3.3 Costs Control 
All participants agreed on the need to carefully examine 
and control all expenditures. “If we consider the rest 
and staff expenditure, a pharmacy must make sales of 3 
to 4 million every month to cover these costs.” (P.12). “A 
model calculation should consider the cost of energy and 
space consumption too". (P.6).
3.4 Financial Management
All participants agreed that it was tedious to collect 
and analyze financial information across pharmacies 
to establish a relationship  between earnings and 
expenditure. In this regard, the following aspects were 
important; the type of software used, software users, 
timely and accurate recording of financial information, 
lack of data in the system, distribution and dissemination 
of financial information. “If the available raw data 
includes the purchase, sales and the costs, we can turn 
the data into good financial reporting, but there is no 
final conclusion."(P.6). “We have created the information 
system in our collection but it is necessary to compel to be 
timely and accurate” (P.4).
3.5 Economic and Political Issues
Issues related to society and nation bear an effect on 
Pharmacy and health system. Participants emphasized 
about the sanctions, inflation, fiscal policy, free and 
dynamic economy as well as the country's drug 
distribution system. “Pharmacy industry and the 
pharmacist are the ones who face the problems with 
respect to Foreign exchange and other sanctions". (P.2). 
Problems in our asset management is seen when different 
drugs have different profit percentage margins, but the 
system calculates all in the same manner of it have a 17% 
profit, but in our asset system all these are calculated in 
the same manner”(P.13).
3.6 Pharmacist
Many participants insisted on guidance on purchase 
strategy and supply, process and personnel management, 
control and monitoring of drug interactions as well as 
technical contributions. In the first group discussion it 
was said: “must be careful in purchases, items that are 
needed, the brands that will be used and prevention of 
longtime purchase” (P.8). “No matter how technically 
correct the pharmacist is, there is no legal right issued by 
parliament to feel comfortable".(P.13).
3.7 Physician
In focus group discussions, most participants agreed 
upon the role of physicians in pharmacy economy. They 
believed that doctors can influence by their presence 
and recommend certain medicines, specific brands and 
write prescriptions accordingly as well as direct patients 
to nearby pharmacies. All these will play a major role 
in Pharmacy economic management. “Problem is 
interacting with doctors. Problems will exist as long 
as prescribed medicines are not available and doctors 
need to be convinced to prescribe as per circulars etc. 
“Pharmacy is always dependent on the doctor, depending 
on the doctor’s prescription, the medication prescribed by 
the doctor...”(P.15).
3.8 Health Insurances
All participants emphasized on issues about Insurance 
deductions, Delayed payment or untimely payment by 
insurance companies, unilateral insurance system and 
lack of proper system in Insurance section. “This system 
is completely one-sided. Therefore, as a pharmacist 
against the health insurance system I do not have any role 
in decision-making” (P.11). One of the factors that affects 
the pharmacy economy is the deductions, where there is a 
loss to the pharmacy profit".(P.8).
3.9 Management System
Form an active drug committee which monitors the 
medicine distribution in the country. Managers should be 
knowledgeable about the financial ratios. The point of view 
by the ministry was another important factor mentioned 
by participants. “A management with poor vision, affects 
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the pharmacy and health care management system, which 
indicates that the perspective of the Ministry of health is 
therapeutic and not pharmaceutical”. (P.11).”I think a lot 
of our managers are not familiar with financial ratios and 
do not know what their applications are...”(P.6).
3.10 Pharmaceutical Companies
From the participant’s point of view, different drug 
importers, different prices of pharmaceutical companies, 
different pharmaceutical companies, and its marketing 
manners are other factors that affect the economic 
and financial pharmacy management. “Iran's generic 
pharmacy plans have changed and now all companies are 
allowed to have their own brand name. While purchasing 
at a pharmacy, this is another problem for us to recall the 
name".(P.14).”Each  pharmaceutical company has its own 
price and this differs across companies. All these make 
the society skeptical” (P.12).
3.11 Cultural Issues
From a participant's perspective, the culture was another 
factor influencing pharmacy management. Patients 
referring to pharmacies, socially settled, conflict between 
traditional and academic culture of pharmacies as well as 
personalized management were all factors affecting the 
pharmacy management. “In the drug issue, consumer 
culture should be considered as a cycle, distribution 
culture,  pharmacy management culture, particular culture 
of the city and neighborhood special culture” needs to be 
considered (P.11). “Recently, pharmacy colleges resumed 
the past continuous cycle for  training pharmacists. Each 
pharmacist, managed pharmacy in his own way...” (P.12).
3.12  Public or Private Pharmacy 
Management System
In participants perspective different management in  public 
and private pharmacies was one of the other factors that 
impact economic and financial management. Participants 
mentioned the key factors, including the difference in the 
number of personnel, costs and objectives, “There is none 
in the private sector. For example, the commission does 
not exist in the private sector, if insurance is delayed in 
private sector, they cancel the contract and do not work 
with that insurance company, but can the government 
do it?” (P.4). “The government system requires a huge 
number of financial and administrative documents along 
with a huge number of personnel...”(P.1).
4.  Discussion
The necessity of implementation of economic and 
financial performance evaluation in a pharmacy was the 
first scope that was examined by specialists and experts. 
The findings of FGDs show that all participants confirm 
the economic and financial evaluation of pharmacy as the 
necessity of health care system and there was a consensus 
among all participants in this regard. 
Review study at the University of Chicago (2009) was 
conducted to evaluate pharmacy services, that emphasized 
on the necessity of evaluation of pharmacy services and 
outcomes. General proposed model for evaluation of 
pharmacy services in this study as Bethany’s study in the 
UK, focused on two aspects of  costs and outcomes of 
pharmacy5,6. Also in another study in the field of hospital 
pharmacies in Canada, the necessity of attention to health 
economic was expressed by the proper use of resources 
especially in the field of hospital pharmacy7. In a study 
that was conducted to survey the status of pharmacy 
information systems of Shahid Beheshti University of 
Medical Sciences affiliated hospitals in 2009, pharmacy 
information systems were semi-mechanized and the 
collecting, reporting and processing of information was 
implemented incompletely8. Therefore, proper design 
and analysis of pharmacy information system, either 
in financial and functional dimension is one of the 
necessities of pharmacy management. 
The problem in evaluating economic performance of 
the pharmacy is poor quality of studies in this field. In 
the review (1987-2005) that was conducted in Zimbabwe, 
limitation and poor quality of studies in the field of 
the financial and economic performance evaluation 
were expressed. Political and economic issues such as 
inflation, poverty, unemployment and diseases such as 
AIDS were the most important factors which affect this 
episode9. In another study in America that was conducted 
at organizational factors affecting the performance of 
pharmacies, operating pharmacy system, volume of 
prescriptions and pharmacy staff were used as the core of 
gathering information10.
Factors affecting the financial and economic 
performance evaluation of pharmacies were one of  the 
another scope that was discussed in the meetings. From 
the participant specialists point of view, pharmacists, 
physicians, medical insurance, management system, 
pharmaceutical companies, cultural issues and public 
or private pharmacy administrative system were most 
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important factors in the evaluation of financial and 
economic performance. In the cross-sectional study  that 
was conducted in Lebanon and Canada pharmacies, the 
professional and influencing role of pharmacists and 
professional behavior of pharmacists were the key factors 
in pharmacy performance. Also in the field of financial 
satisfaction, 50 % of the pharmacists who had private 
pharmacies were satisfied but hospital pharmacies were 
dissatisfied.  This reflects the importance of the pharmacy 
administrative system. 
In a study that was conducted in 2003 in hospitals, 
attention was paid to key issues related to medical costs. 
The key role of doctors and their prescribed medication in 
rising costs were one of these factors11. Public or private 
administrative pharmacy system was one of the very 
important factors that the expert participants emphasized 
on its importance on the economic and financial 
performance evaluation. Some of the participants 
expressed the need for devolution of hospital pharmacy 
to private sector and the positive experiences in this field. 
In Tourani et al. study that was conducted to compare 
the effectiveness and efficiency of Firoozgar Hospital 
pharmacy before and after the outsourcing, findings of 
the study showed that after outsourcing the number of 
pharmacy prescriptions increased and huge amounts of 
personal costs and pharmacy expenditure were saved 
monthly. This represents that outsourcing of Firoozgar 
Hospital pharmacy was successful12.
5.  Conclusion
Based on the results of this study, necessary criteria 
and indicators to assess the economic and financial 
performance of pharmacies as per professional and 
experts view were identified. Using the results of this 
study an effective tool to evaluate economic and financial 
performance of pharmacies can be developed.
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